279 related articles for article (PubMed ID: 3818608)
1. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence.
Kemp BE; Pearson RB; Guerriero V; Bagchi IC; Means AR
J Biol Chem; 1987 Feb; 262(6):2542-8. PubMed ID: 3818608
[TBL] [Abstract][Full Text] [Related]
2. Rabbit skeletal muscle myosin light chain kinase. The calmodulin binding domain as a potential active site-directed inhibitory domain.
Kennelly PJ; Edelman AM; Blumenthal DK; Krebs EG
J Biol Chem; 1987 Sep; 262(25):11958-63. PubMed ID: 3624242
[TBL] [Abstract][Full Text] [Related]
3. Spatial requirements for location of basic residues in peptide substrates for smooth muscle myosin light chain kinase.
Kemp BE; Pearson RB
J Biol Chem; 1985 Mar; 260(6):3355-9. PubMed ID: 3838312
[TBL] [Abstract][Full Text] [Related]
4. Role of the pseudosubstrate sequence in smooth muscle myosin light chain kinase thermal stability.
Faux MC; Pearson RB; Mitchelhill KI; Kemp BE
J Biol Chem; 1993 Jun; 268(17):12484-91. PubMed ID: 8509388
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin binding domains: characterization of a phosphorylation and calmodulin binding site from myosin light chain kinase.
Lukas TJ; Burgess WH; Prendergast FG; Lau W; Watterson DM
Biochemistry; 1986 Mar; 25(6):1458-64. PubMed ID: 3754463
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of a synthetic heptadecapeptide by smooth muscle myosin light chain kinase.
Kemp BE; Pearson RB; House C
J Biol Chem; 1982 Nov; 257(22):13349-53. PubMed ID: 6897243
[TBL] [Abstract][Full Text] [Related]
7. Autoregulation of enzymes by pseudosubstrate prototopes: myosin light chain kinase.
Pearson RB; Wettenhall RE; Means AR; Hartshorne DJ; Kemp BE
Science; 1988 Aug; 241(4868):970-3. PubMed ID: 3406746
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the calmodulin-binding and catalytic domains in skeletal muscle myosin light chain kinase.
Edelman AM; Takio K; Blumenthal DK; Hansen RS; Walsh KA; Titani K; Krebs EG
J Biol Chem; 1985 Sep; 260(20):11275-85. PubMed ID: 3897230
[TBL] [Abstract][Full Text] [Related]
9. Properties of a monoclonal antibody directed to the calmodulin-binding domain of rabbit skeletal muscle myosin light chain kinase.
Nunnally MH; Blumenthal DK; Krebs EG; Stull JT
Biochemistry; 1987 Sep; 26(18):5885-90. PubMed ID: 2445376
[TBL] [Abstract][Full Text] [Related]
10. Three amino acid substitutions in domain I of calmodulin prevent the activation of chicken smooth muscle myosin light chain kinase.
VanBerkum MF; Means AR
J Biol Chem; 1991 Nov; 266(32):21488-95. PubMed ID: 1657969
[TBL] [Abstract][Full Text] [Related]
11. Minimum requirements for inhibition of smooth-muscle myosin light-chain kinase by synthetic peptides.
Hunt JT; Floyd DM; Lee VG; Little DK; Moreland S
Biochem J; 1989 Jan; 257(1):73-8. PubMed ID: 2920029
[TBL] [Abstract][Full Text] [Related]
12. Smooth muscle myosin light chain kinase. Amino acid sequence at the site phosphorylated by adenosine cyclic 3',5'-phosphate-dependent protein kinase whether or not calmodulin is bound.
Payne ME; Elzinga M; Adelstein RS
J Biol Chem; 1986 Dec; 261(35):16346-50. PubMed ID: 3782123
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
[TBL] [Abstract][Full Text] [Related]
14. Primary and tertiary structure of the principal human adenylate kinase.
Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
[TBL] [Abstract][Full Text] [Related]
15. Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.
Foster CJ; Johnston SA; Sunday B; Gaeta FC
Arch Biochem Biophys; 1990 Aug; 280(2):397-404. PubMed ID: 2369131
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyamino acid specificity of smooth muscle myosin light chain kinase.
Pearson RB; Floyd DM; Hunt JT; Lee VG; Kemp BE
Arch Biochem Biophys; 1988 Jan; 260(1):37-44. PubMed ID: 3341750
[TBL] [Abstract][Full Text] [Related]
17. Primary structure required for the inhibition of smooth muscle myosin light chain kinase.
Ikebe M; Reardon S; Fay FS
FEBS Lett; 1992 Nov; 312(2-3):245-8. PubMed ID: 1426258
[TBL] [Abstract][Full Text] [Related]
18. Biochemical properties of chimeric skeletal and smooth muscle myosin light chain kinases.
Leachman SA; Gallagher PJ; Herring BP; McPhaul MJ; Stull JT
J Biol Chem; 1992 Mar; 267(7):4930-8. PubMed ID: 1371510
[TBL] [Abstract][Full Text] [Related]
19. Intrasteric regulation of myosin light chain kinase: the pseudosubstrate prototope binds to the active site.
Bagchi IC; Kemp BE; Means AR
Mol Endocrinol; 1992 Apr; 6(4):621-6. PubMed ID: 1584224
[TBL] [Abstract][Full Text] [Related]
20. Interaction of calmodulin and a calmodulin-binding peptide from myosin light chain kinase: major spectral changes in both occur as the result of complex formation.
Klevit RE; Blumenthal DK; Wemmer DE; Krebs EG
Biochemistry; 1985 Dec; 24(27):8152-7. PubMed ID: 3841496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
